Multiple regression methodologies have been developed, integrating the apolipoprotein E (APOE) ε4 haplotype—a recognized significant sporadic AD risk factor—alongside various other AD risk SNPs identified through GWAS and polygenic risk scores. Here, APOE is linked to Alzheimer disease.